The Malignant Lymphoma Market is witnessing a notable rise in market volume, projected to reach USD 10.72 billion by 2035, growing at a CAGR of 6.7%. This upward trend is indicative of the increasing demand for innovative treatment modalities that are reshaping the landscape of lymphoma care. The healthcare sector is experiencing a pivotal shift, where traditional treatment options are being...